Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (191-200 of 429) with videos related to

Pageof 43
Sort By:
JCO Precision Oncology|May 22, 2026
Prevalence of Germline Pathogenic <i>RET</i> Variants in a Pan-Cancer Patient PopulationMatilde Borio, Margaret Sheehan, Nora Katabi, et al.
JCO Precision Oncology|August 10, 2023
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid TumorsSebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin, et al.
Journal of the National Cancer Institute|July 9, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni SyndromeOzge Ceyhan-Birsoy, Pier Selenica, M Herman Chui, et al.
BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-AnalysisMelissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.
Nature Genetics|August 30, 2011
Germline mutations in BAP1 predispose to melanocytic tumorsThomas Wiesner, Anna C Obenauf, Rajmohan Murali, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
American Journal of Human Genetics|August 7, 2012
Rare de novo germline copy-number variation in testicular cancerZsofia K Stadler, Diane Esposito, Sohela Shah, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
Cancer Letters|June 24, 2008
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancerMarc D Tischkowitz, Ahmet Yilmaz, Long Q Chen, et al.
Pageof 43

Showing results (191-200 of 429) with videos related to

Sort By:
Pageof 43
JCO Precision Oncology|May 22, 2026
Prevalence of Germline Pathogenic <i>RET</i> Variants in a Pan-Cancer Patient PopulationMatilde Borio, Margaret Sheehan, Nora Katabi, et al.
JCO Precision Oncology|August 10, 2023
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid TumorsSebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin, et al.
Journal of the National Cancer Institute|July 9, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni SyndromeOzge Ceyhan-Birsoy, Pier Selenica, M Herman Chui, et al.
BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-AnalysisMelissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.
Nature Genetics|August 30, 2011
Germline mutations in BAP1 predispose to melanocytic tumorsThomas Wiesner, Anna C Obenauf, Rajmohan Murali, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
American Journal of Human Genetics|August 7, 2012
Rare de novo germline copy-number variation in testicular cancerZsofia K Stadler, Diane Esposito, Sohela Shah, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
Cancer Letters|June 24, 2008
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancerMarc D Tischkowitz, Ahmet Yilmaz, Long Q Chen, et al.
Pageof 43